cnn tirzepatide A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Company hikes Mounjaro prices in

The finding, published in Genome Medicine , is the product of a decade-long international collaboration spanning experiments in humans and mice, clinical trial data from over a thousand participants, and biochemistry that kept delivering results nobody anticipated

Obesity now affects more than a billion people worldwide, according to a study published in March in the British medical journal The Lancet.

Brand-name GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are manufactured by pharmaceutical companies, undergo extensive FDA clinical trials, and are approved as finished drug products with fixed dosing options

Cold chain failures GLP-1 medications such as Mounjaro require refrigerated storage and are typically shipped with insulated packaging and ice packs

The American Heart Association's Heart Disease and Stroke Statistics report has documented significant racial disparities in comorbidity management outcomes and healthcare delivery [116]